The study will examine the effects that Metformin Hydrochloride has on Prostate Specific Antigen levels in men with Prostate Cancer.
Winthrop University Hospital Clinical Trials Center is conducting this clinical research study for men ages 18 and older who have biopsy proven Prostate Cancer.
Metformin therapy for patients diagnosed with Prostate Cancer who have been treated with either radiation therapy or surgery who have indicators of high risk disease, or who have a rising Prostate Specific Antigen after treatment.
Eligible participants will receive study-related medical examinations, research medication and laboratory tests at no cost, while they are participating in this clinical research study.
Condition | Prostate Cancer |
---|---|
Clinical Study Identifier | TX140022 |
Last Modified on | 23 November 2020 |
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreEvery year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.